Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roemer

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Electrophoresis|August 1, 1992
Continuous, on-line DNA sequencing using a versatile infrared laser scanner/electrophoresis apparatusL R Middendorf, J C Bruce, R C Bruce, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 29, 2003
Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC studyK M Smits, L Gaspari, M P Weijenberg, et al.
Journal of Occupational and Environmental Medicine|March 2, 2010
Second-year results of an obesity prevention program at the Dow Chemical CompanyRon Z Goetzel, Enid C Roemer, Xiaofei Pei, et al.
Elife|October 1, 2016
The Cac1 subunit of histone chaperone CAF-1 organizes CAF-1-H3/H4 architecture and tetramerizes histonesWallace H Liu, Sarah C Roemer, Yeyun Zhou, et al.
Journal of Occupational and Environmental Medicine|February 12, 2009
First-year results of an obesity prevention program at The Dow Chemical CompanyRon Z Goetzel, Kristin M Baker, Meghan E Short, et al.
Gynecologic Oncology|December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)F T Roncolato, R L O'Connell, F Joly, et al.
British Journal of Cancer|January 11, 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO groupP-E Heudel, M Fabbro, C Roemer-Becuwe, et al.
La Revue De Medecine Interne|March 8, 2011
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma]J F Brantus, C Roemer-Becuwe, P Cony-Makhoul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2019
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I studyF Joly, D Ahmed-Lecheheb, E Kalbacher, et al.
Archives of Toxicology|April 26, 2012
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer riskSilvia Selinski, Marie-Louise Lehmann, Meinolf Blaszkewicz, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Electrophoresis|August 1, 1992
Continuous, on-line DNA sequencing using a versatile infrared laser scanner/electrophoresis apparatusL R Middendorf, J C Bruce, R C Bruce, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 29, 2003
Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC studyK M Smits, L Gaspari, M P Weijenberg, et al.
Journal of Occupational and Environmental Medicine|March 2, 2010
Second-year results of an obesity prevention program at the Dow Chemical CompanyRon Z Goetzel, Enid C Roemer, Xiaofei Pei, et al.
Elife|October 1, 2016
The Cac1 subunit of histone chaperone CAF-1 organizes CAF-1-H3/H4 architecture and tetramerizes histonesWallace H Liu, Sarah C Roemer, Yeyun Zhou, et al.
Journal of Occupational and Environmental Medicine|February 12, 2009
First-year results of an obesity prevention program at The Dow Chemical CompanyRon Z Goetzel, Kristin M Baker, Meghan E Short, et al.
Gynecologic Oncology|December 15, 2019
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy - The GCIG symptom benefit study (SBS)F T Roncolato, R L O'Connell, F Joly, et al.
British Journal of Cancer|January 11, 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO groupP-E Heudel, M Fabbro, C Roemer-Becuwe, et al.
La Revue De Medecine Interne|March 8, 2011
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma]J F Brantus, C Roemer-Becuwe, P Cony-Makhoul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2019
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I studyF Joly, D Ahmed-Lecheheb, E Kalbacher, et al.
Archives of Toxicology|April 26, 2012
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer riskSilvia Selinski, Marie-Louise Lehmann, Meinolf Blaszkewicz, et al.
Pageof 5